Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Novo Nordisks semaglutide (Ozempic for diabetes, Wegovy for obesity) and Eli Lillys dual-agonist tirzepatide (Mounjaro, a related drug that also activates the GIP hormone receptor) have become blockbusters , propelling their companies to record-high market valuations ( [15] ) ( [16] )
In April 2026, CMS announced it would not move forward with the Part D portion of BALANCE in 2027, citing the need for more data and a smoother transition
Managing fiber intake during the adjustment period is essential
Start your morning
Inhibitors of CYP2B6 Ticlopidine and Clopidogrel: Concomitant treatment with these drugs can increase bupropion exposure but decrease hydroxybupropion exposure
US$ 28.91
US$ 23.68
US$ 26.59
US$ 21.77
US$ 28.84
US$ 23.88
US$ 23.51
